AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Four months after Intel shut it down, Ignite relaunches as an independent accelerator
2
Boomi acquires Israeli data management startup Rivery in $100M deal
3
Israel launches its first domestically built quantum computer
4
Spyware startup Paragon acquired for up to $900M by investment firm AE
5
“I foresee one of the best decades in the history of the State of Israel”
More news

Drugs

20 stories about Drugs
אלרגן משרדים

Court Rules Allergan Can't Use Indian Tribe Deal to Protect Patents

23.07.18|CTech
In September 2017, Allergan transferred six of its patents for blockbuster dry eye drug Restasis to the St. Regis Mohawk Tribe, hoping to protect the patents under the principle of sovereign immunity
רון בנצור

Sustained Drug Release Company UroGen Submits New Drug Application to FDA

12.07.18|Amir Rosenbaum
Kite Pharma founder Arie Belldegrun is the chairman of Israel-based UroGen, which focuses mainly on cancer treatment and urinary tract infections
ה מטה הנוכחי של טבע ב ארה"ב

Mylan Cuts Price of Generic Copaxone Offering by 60%

11.07.18|Lilach Baumer
Mylan has achieved a 15%-20% market share in the U.S. since launching its generic version in late 2017 with a monthly price tag of $5,000, compared to Teva's $5,800
נאסד"ק וול סטריט

Oral Insulin Capsule Developer Oramed Raises $18 Million in Direct Offering

10.07.18|CTech
Jerusalem-headquartered Oramed intends to use the recent proceeds for research and development and for clinical trials
קאר שולץ מנכל טבע

Teva to Relocate U.S. Headquarters to New Jersey

08.07.18|Lilach Baumer
In December, the Israeli drugmaker announced a far-reaching cost cutting plan to deal with its multi-billion debt
חדר מיון בית חולים שיבא תל השומר

Cost-Cutting at CureTech Following Cancellation of Acquisition Deal with Insight

05.07.18|CTech
The deal was announced in March, but intended buyer InSight backed out
נאסד"ק וול סטריט

Fourth Time’s the Charm for Entera Bio IPO

01.07.18|Dror Reich
The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each
קאר שולץ מנכל טבע

Goldman Sachs Sees 16% Upside in Teva Stock

26.06.18|Dror Reich
Following a meeting with Teva’s management, the bank's analysts reiterated their "buy" recommendation with a higher target price
Ferring Per Falk

At Swiss Pharma Company, Women’s Health Gets Personal

23.05.18|Lilach Baumer
Ferring Pharmaceuticals recently launched a personalized fertility treatment that supports its hormone therapy with a dosage calculation app
תרופות זירת הבריאות

Entera Bio Gives Nasdaq IPO Another Shot

21.05.18|Dror Reich
This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq
דפנה קולר מייסדת ו נשיאה קורסרה coursera הוועידה המוטסת גלריה

Coursera Co-Founder Daphne Koller Launches New AI Drug Development Startup

06.05.18|Tofi Stoler
In February, Ms. Koller left her position as chief computing officer at Google’s biotech company Calico
מטה טבע פתח תקווה

Building on Strong First Quarter, Teva Raises 2018 Outlook

03.05.18|Lilach Baumer and Dror Reich
The company reported a 10% decrease in revenues compared to 2017, largely due to North American Copaxone troubles, but beat analyst expectations
מוסף 16.5 הון אנושי סול ג'יי בארר Sol J. Barer

Three Board Members to Leave Distraught Drugmaker Teva

26.04.18|Lilach Baumer and Dror Reich
Teva, one of the world's largest generic drugmakers, has faced increasing difficulties the past two years
מטה טבע פתח תקווה

Teva Blocked From Launching Generic Version of Israeli Sleep Medicine Circadin

17.04.18|Zohar Shahar Levy and Dror Reich
An Israeli court issued a temporary injunction against Teva, following a lawsuit by the brand drug's maker Neurim Pharmaceuticals
הפגנה מפגינים פיטורים טבע אשדוד

With No Buyers, Teva to Close Israeli Medical Equipment Plant

09.04.18|Dror Reich
The facility in Ashdod is one of five Teva intends to sell or close in its home country
עלה קנאביס

Israeli Pharmacies To Begin Selling Medical Marijuana Products

09.04.18|Sefi Krupsky
On April 20, selected Israeli pharmacies will begin selling prescription cannabis products as part of a pilot program for the regulation of medical marijuana sales in Israel
חיים הורביץ איש עסקים דירקטור ב חברת טבע

Stock Market Downturn Leads Biotech Company Polypid to Backtrack on IPO

25.03.18|Dror Reich
The Israel-based company has postponed its planned IPO after Nasdaq, Dow Jones trended down heavily last week
נאסדק נאסד"ק ניו יורק בורסה בועה

Biotech Company Polypid Aims to Raise $75 Million with Nasdaq IPO

15.03.18|Dror Reich
The Israel-based company develops a pharmaceutical mechanism that slows down drug delivery
יו"ר ועד עובדי טבע כפר סבא אלירן קוזליק

In Protest of New Bonus Plan, Teva Sued by Israeli Employees

15.03.18|Dror Reich
After announcing the cancellation of its annual bonuses for 2017 due to debt, the Israel-based drugmaker rolled out a performance-based bonus scheme for 2018 in February
מנכ"ל טבע החדש קור שולץ 2

Teva Increases Junk Senior Note Offering to $4.5 Billion

08.03.18|Lilach Baumer
Last week the debt-laden drugmaker announced a $3.5 billion-equivalent offering to repay its short-term $1.5 billion outstanding debt due July
Previous ArticlesMore Articles